Although all three genomic scars are highly correlated with each other in certain cancer types such as breast cancer [35,36] and can individually predict BRCA1/2 mutational status, the combination of TAI, LOH, and LST parameters was found to perform best at distinguishing HR proficient from deficient tumors [29,37]. The gene discussed is BRCA1; the disease is cancer.